Latest topics page 28
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 28 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Availability by country, dated, with primary sources — one year on
Availability by country, dated, with primary sources — one year on — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this…
|
+7 | 11 | 850 | 7mo |
|
Follow-up: The decimal-point error, and the habit that catches it
On the subject in the title: The decimal-point error, and the habit that catches it Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am asking…
|
+118 | 131 | 50k | 7mo |
|
Reading SURMOUNT-1 without the press release
Posting this under the heading it deserves: Reading SURMOUNT-1 without the press release Everything below is what sits behind that. I have seen SURMOUNT-4 ( JAMA , 2024) cited in support of a claim I do not…
|
+103 | 121 | 7k | 7mo |
|
Hair shedding at month three: mechanism and time course
On the subject in the title: Hair shedding at month three: mechanism and time course Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is useful to…
|
2 | 47k | 7mo | |
|
Vomiting: when it is expected and when it is a reason to stop
Posting this under the heading it deserves: Vomiting: when it is expected and when it is a reason to stop Everything below is what sits behind that. Reporting something rather than asking about it, in case…
|
+116 | 124 | 43k | 7mo |
|
Batch date after test date, and other internal inconsistencies
Batch date after test date, and other internal inconsistencies — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it…
|
+27 | 31 | 4.9k | 7mo |
|
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it
On the subject in the title: Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please…
|
+2 | 6 | 2.4k | 7mo |
|
Prescription requirements and telehealth models
Prescription requirements and telehealth models Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than anywhere…
|
+91 | 97 | 5.4k | 7mo |
|
What a regulator's shortage notice actually authorises — what changed since
The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats it. A logistics question, since the…
|
+22 | 26 | 53k | 7mo |
|
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold?
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SURMOUNT-4 (…
|
+21 | 25 | 45k | 7mo |
|
Substitution between formats during a shortage
On the subject in the title: Substitution between formats during a shortage Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…
|
+114 | 123 | 47k | 7mo |
|
Meeting a protein target on a suppressed appetite
Meeting a protein target on a suppressed appetite Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a number without a…
|
+39 | 44 | 11k | 7mo |
|
Measurement error in home scales, with a worked standard deviation — a second dataset
Measurement error in home scales, with a worked standard deviation — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med , 2024) with SURPASS-2…
|
2 | 13k | 7mo | |
|
An inter-laboratory comparison on one lot, tabulated — what changed since
An inter-laboratory comparison on one lot, tabulated — what changed since — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I…
|
+24 | 28 | 3.3k | 7mo |
|
Personal import allowances, compared
On the subject in the title: Personal import allowances, compared Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of July 2026, in…
|
+5 | 9 | 3.2k | 7mo |
|
Follow-up: Sodium, potassium and magnesium when intake drops
On the subject in the title: Sodium, potassium and magnesium when intake drops Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is not a…
|
+8 | 12 | 335 | 7mo |
|
Pricing far outside the range, in either direction
Posting this under the heading it deserves: Pricing far outside the range, in either direction Everything below is what sits behind that. Structured report rather than an opinion, following the format the…
|
+3 | 7 | 27k | 7mo |
|
Airline travel with a temperature-sensitive injectable
Posting this under the heading it deserves: Airline travel with a temperature-sensitive injectable Everything below is what sits behind that. A question about technique rather than about dose. I have been…
|
+19 | 23 | 4.9k | 7mo |
|
Coming back to: Over-dilution: when your dose falls below one readable graduation
Over-dilution: when your dose falls below one readable graduation Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a…
|
+90 | 97 | 1.1k | 7mo |
|
Comparing my trajectory with the trial curves, carefully
Posting this under the heading it deserves: Comparing my trajectory with the trial curves, carefully Everything below is what sits behind that. Maintenance rather than loss, which is the part of this that…
|
+86 | 92 | 54k | 7mo |
|
[2026 update] Whether protein timing matters at a large deficit
Whether protein timing matters at a large deficit — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated, because a number without a method is not a…
|
+4 | 8 | 46k | 7mo |
|
DXA precision and the least significant change for lean mass
Posting this under the heading it deserves: DXA precision and the least significant change for lean mass Everything below is what sits behind that. Maintenance rather than loss, which is the part of this that…
|
+81 | 85 | 2.7k | 7mo |
|
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a…
|
+64 | 69 | 15k | 7mo |
|
The decimal-point error, and the habit that catches it
The decimal-point error, and the habit that catches it Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have seen how…
|
+110 | 121 | 10k | 7mo |
|
Publishing an inconvenient result: a case study — the long version
Publishing an inconvenient result: a case study — the long version Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
|
+68 | 74 | 12k | 7mo |
|
[2026 update] Conference abstracts as evidence: the weakest common citation
Conference abstracts as evidence: the weakest common citation — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURMOUNT-4 ( JAMA , 2024) and finding…
|
2 | 48k | 7mo | |
|
Coming back to: Feature request: should a dose-equivalence tool exist at all?
Feature request: should a dose-equivalence tool exist at all? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first…
|
+37 | 41 | 725 | 7mo |
|
Persistent vomiting and the threshold for seeking help
On the subject in the title: Persistent vomiting and the threshold for seeking help Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference…
|
+82 | 88 | 31k | 7mo |
|
Why tirzepatide titration schedules have more steps than semaglutide's
Asking directly, because I could not find a straight answer: Why tirzepatide titration schedules have more steps than semaglutide's Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
4 | 8.4k | 7mo | |
|
Tracking a preprint to publication: a worked example
Tracking a preprint to publication: a worked example Writing it up because I had to work it out twice and would rather nobody else did. Session topic: STEP 1 ( N Engl J Med , 2021). Please read it before…
|
+133 | 147 | 15k | 7mo |